Escuela de doctorado
FARMACIA Y SALUD
Artículos (24) Publicaciones en las que ha participado algún/a investigador/a
2009
-
A powerful chiral counteranion motif for asymmetric catalysis
Angewandte Chemie - International Edition, Vol. 48, Núm. 24, pp. 4363-4366
-
Antioxidant activity of a red lentil extract and its fractions
International Journal of Molecular Sciences, Vol. 10, Núm. 12, pp. 5513-5527
-
Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats
European Journal of Pharmacology, Vol. 620, Núm. 1-3, pp. 90-96
-
Comparative study of the phenolic composition in lentils processed with and without addition of commercial tannase
Journal of Food Processing and Preservation, Vol. 33, Núm. 6, pp. 695-713
-
Desarrollo de la docencia práctica de las carreras experimentales en el ámbito de Bolonia
Papeles salmantinos de educación, Núm. 12, pp. 127-136
-
Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats
Analytical and Bioanalytical Chemistry, Vol. 394, Núm. 6, pp. 1545-1556
-
Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients
Journal of Pharmacy and Pharmacology, Vol. 61, Núm. 6, pp. 759-766
-
Germination as a process to increase the polyphenol content and antioxidant activity of lupin seeds (Lupinus angustifolius L.)
Food Chemistry, Vol. 117, Núm. 4, pp. 599-607
-
Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta
Atherosclerosis, Vol. 204, Núm. 1, pp. 34-39
-
Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes
European Journal of Pharmaceutical Sciences, Vol. 38, Núm. 4, pp. 320-324
-
Industria Farmacéutica: un reto para la innovación en Castilla y León
Boletín económico de Castilla y León, Núm. 17, pp. 47-48
-
Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients
Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 7, pp. 2791-2798
-
Intervención farmacéutica en el seguimiento de la terapia antirretroviral
Anales de la Real Academia Nacional de Farmacia, Núm. 1, pp. 43-62
-
Isocombretastatins A: 1,1-Diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds
Bioorganic and Medicinal Chemistry, Vol. 17, Núm. 17, pp. 6422-6431
-
La formación universitaria de postgrado hacia la industria farmacéutica
Boletín económico de Castilla y León, Núm. 17, pp. 49-50
-
Phenolic acids determination by HPLC-DAD-ESI/MS in sixteen different Portuguese wild mushrooms species
Food and Chemical Toxicology, Vol. 47, Núm. 6, pp. 1076-1079
-
Population pharmacokinetics of albendazole in patients with neurocysticercosis
International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, Núm. 11, pp. 679-685
-
Preparation and characterization of Catechin sulfates, glucuronides, and methylethers with metabolic interest
Journal of Agricultural and Food Chemistry, Vol. 57, Núm. 4, pp. 1231-1238
-
Pyrazolo[3,4,5-de]phthalazine. Syntheses of a practically unknown heterocyclic system
Tetrahedron, Vol. 65, Núm. 8, pp. 1574-1580
-
Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis
Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 19, pp. 5764-5768